Stay Updated
Press Releases
PHARMA DEFEAT: Federal Court Rejects U.S. Chamber of Commerce’s Case Against Medicare Negotiation
The U.S. Court of Appeals for the Sixth Circuit stood with the lower court’s 2024 decision to dismiss the U.S. Chamber of Commerce’s Case WASHINGTON, D.C. — In another blow to pharma’s multi-million dollar legal campaign against the Medicare Negotiation Program, today the Sixth Circuit U.S. Court of Appeals blocked a legal challenge to […]
Press Releases
Analysis found that drug research spending “increased to record levels” in the six quarters following the IRA’s passage in 2022 WASHINGTON, D.C. — New analysis from Bentley University demolishes Big Pharma’s core talking point that Medicare negotiation would kill drug research and development (R&D). The study found that after flatlining from 2020 to 2022, drug […]
Press Releases
ICYMI: P4AD Releases Report Exposing Six Pharma-Funded Front Groups Keeping Drug Prices High
WASHINGTON, D.C. — Last week, Patients For Affordable Drugs released a new report, The Rampant Reach of Pharma’s Hidden Hand, uncovering the pharmaceutical industry’s efforts to fund, influence — and in some cases, fully operate — front groups that claim to represent the interests of patients while working to protect drug company profits. Each of […]
Press Releases
Third iteration of Hidden Hand report aimed at helping policymakers and media gain a clearer picture of pharma-aligned groups WASHINGTON, D.C. — Today, Patients For Affordable Drugs is releasing a new report, The Rampant Reach of Pharma’s Hidden Hand, uncovering the pharmaceutical industry’s latest efforts to fund, influence — and in some cases, fully operate — front […]
Press Releases
WASHINGTON, D.C. —Today, the U.S. Court of Appeals for the Third Circuit rejected AstraZeneca’s challenge to the Medicare Drug Price Negotiation Program. The unanimous ruling marks the first appellate decision to evaluate and uphold the legality of the program’s core framework, dealing a major blow to pharmaceutical industry efforts to block lower drug prices. Patients For […]
Press Releases
ICYMI: David Mitchell Named One of Washington’s Most Influential People for Third Year in a Row
WASHINGTON, D.C. — Patients For Affordable Drugs’ founder and president, David Mitchell, has once again been included in Washingtonian’s Washington DC’s 500 Most Influential People of 2025. This marks the third consecutive year David has been recognized for his tireless work to lower prescription drug prices for patients across the country. “David’s relentless commitment to reforming the drug […]
Press Releases
To our Community, Today marks one hundred days into the new presidential administration. A key moment to take stock and reflect on where we are in the fight to lower drug prices for all Americans. Over the past several weeks, we’ve heard directly from nearly 1,000 people in our community – patients, family members, caregivers […]
Press Releases
Voters — including a majority of Trump supporters — demand action to lower drug prices as Big Pharma’s favorability plummets. WASHINGTON, D.C. — A new poll released last week, conducted by Trump pollster Fabrizio Ward and commissioned by Arnold Ventures, reveals just how potent the issue of prescription drug pricing has become, not just with voters overall, but with an overwhelming […]